man MS wheelchair The Food and Drug Administration (FDA) has placed a partial hold on clinical trials for the intrathecal administration of AVXS-101 (AveXis, a Novartis Company) in patients with ...
We performed a phase I trial of intrathecal (IT) liposomal cytarabine (DepoCyt; Enzon Pharmaceuticals, Piscataway, NJ and SkyePharma Inc, San Diego, CA) to determine the maximum-tolerated dose, the ...
Intrathecal Trials of AVXS-101 (Zolgensma) in SMA Halted The partial hold on trials of intrathecal administration stem from safety concerns in animals and does not affect Zolgensma intravenous ...
Findings from two clinical trials suggest Novartis' Itvisma is safe and effective for SMA patients over 2 years old.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...
The patient demonstrated two neuropathic pain syndromes, namely at- and below-level pain. These syndromes were recalcitrant to conservative measures and a decision was made to proceed with intrathecal ...
Panelists discuss how emerging intrathecal gene therapy for older patients with spinal muscular atrophy (SMA) shows modest efficacy with fewer systemic adverse effects than intravenous administration, ...
Objective: To report treatment of spasticity in a spinal cord-injured person with intrathecal morphine after the person developed tolerance to intrathecal baclofen. Method: Spasticity in a 36-year-old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback